6505--RX - pylarify (piflufolastat F 18 injection) (NDC 71258-0022-01)

The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 2 (VISN 2) is conducting a market research initiative to identify potential sources for Pylarify (Piflufolastat F 18 Injection), a radiopharmaceutical imaging agent classified under National Drug Code 71258-0022-01. The solicitation seeks responses from businesses of all sizes, including manufacturers and distributors, operating under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) and PSC Code 6505 (Drugs and Biologicals). Interested firms must submit their responses by January 12, 2026, at 10 AM Eastern Time, providing company name, socioeconomic category, complete address, and contact information via email to Aleta.Jennette@va.gov or through GSA E-buy. The radiopharmaceutical will be delivered to VISN 2 Downstate Hospitals, with specific delivery locations to be determined in subsequent communications. This is explicitly a sources sought notice for market research purposes only and does not constitute a formal solicitation, commitment to award, or obligation to compensate respondents for their information.

No set-aside designations have been applied to this procurement opportunity. No incumbent contractors or current suppliers are identified in the available documentation. The notice does not specify an award value, budget range, or quantity requirements, as this pre-solicitation phase is designed to assess market capability and interest rather than to execute a purchase order. The 90-day archive period following the January 12, 2026 response deadline will allow the VA to evaluate submitted information and determine next steps for potential formal solicitation. The primary point of contact for inquiries is Contracting Officer Aleta Jennette, reachable at (914) 737-4400 extension 2068 or via email.